SuperworthBaxter International EPS BAX
Diluted earnings per share by quarter and over the last twelve months, from 2008.
- Last 12 months, to Jun 30, 2026
- −$2.08
- Latest quarter, Q2 FY26
- $0.24
- +33% on a year earlier
- Fiscal year 2025
- −$1.86
Baxter International's earnings per share was −$2.08 over the twelve months to Jun 30, 2026.
In its latest quarter, Q2 FY26, it was $0.24, up 33% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | −$1.86 | n/a |
| FY2024 | −$1.27 | −124% |
| FY2023 | $5.22 | n/a |
| FY2022 | −$4.83 | −291% |
| FY2021 | $2.53 | +18% |
| FY2020 | $2.14 | +11% |
| FY2019 | $1.92 | −32% |
| FY2018 | $2.83 | +119% |
| FY2017 | $1.29 | −86% |
| FY2016 | $8.99 | +414% |
| FY2015 | $1.75 | −62% |
| FY2014 | $4.56 | +25% |
| FY2013 | $3.65 | −13% |
| FY2012 | $4.18 | +8% |
| FY2011 | $3.88 | +62% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.24 | +33% | −$2.08 | |
| Q1 FY26 | −$0.03 | −112% | −$2.14 | |
| Q4 FY25 | −$2.20 | n/a | −$1.86 | |
| Q3 FY25 | −$0.09 | −133% | −$0.66 | |
| Q2 FY25 | $0.18 | n/a | −$0.30 | |
| Q1 FY25 | $0.25 | +257% | −$1.09 | |
| Q4 FY24 | −$1.00 | −308% | −$1.27 | |
| Q3 FY24 | $0.27 | −95% | $0.21 | |
| Q2 FY24 | −$0.61 | n/a | $4.87 | |
| Q1 FY24 | $0.07 | −22% | $5.20 | |
| Q4 FY23 | $0.48 | +33% | $5.22 | |
| Q3 FY23 | $4.93 | n/a | $5.10 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Baxter International's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| BAXBaxter International | −$2.08 | |
| PENPenumbra | $4.07 | +8% a year |
| SOLVSolventum | $8.18 | +277% a year |
| COOCooper Companies | $2.93 | +44% a year |
| ALGNAlign Technology | $5.75 | −3% a year |
| GMEDGlobus Medical | $3.91 | +50% a year |
| PODDInsulet | $5.35 | +64% a year |
| MSAMSA Safety | $8.04 | +15% a year |
| WSTWest Pharmaceutical Services | $7.81 | +17% a year |
| MMSIMerit Medical Systems | $2.42 | +23% a year |
| HAEHaemonetics | $2.04 | −38% a year |
| Peer median | $4.71 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Baxter International
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.